Zheng Zhaoxia, Hu Lei, Zhang Yue, Liu Nianen, Gu Xiaoya, Song Shuang, Yu Xiaobing
Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China; Graduate School of Peking Union Medical College, Beijing, China.
Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
Microvasc Res. 2025 Sep;161:104832. doi: 10.1016/j.mvr.2025.104832. Epub 2025 Jun 20.
To investigate choroidal changes in different stages of diabetic retinopathy (DR), and determine the effect of panretinal photocoagulation (PRP) on choroid based on volumetric measurements of ultrawide-field swept-source optical coherence tomography angiography (UWF-SS-OCTA).
This observational study included 56 healthy controls, 192 treatment-naïve DR patients, and 42 PRP-treated DR patients who have undergone UWF-SS-OCTA measurements. Treatment-naïve DR patients were further grouped according to varying severity of DR. Choroidal parameters were analyzed and compared among these groups according to central and peripheral areas. Spearman analysis was performed to determine the association between non-perfusion area (NPA) and choroidal parameters.
Compared with healthy controls, choroidal thickness (CT) and volume (CV), including both vascular and stromal volume (CVV/a and CSV/a) were decreased in treatment-naïve DR patients in full range, while choroidal vascularity index (CVI) decreased only in the peripheral area (P = 0.04). In detail, choroid was thinning in no-DR (NDR) and mild NPDR, followed by an increased trend in moderate and late stages of DR. NPA was positively associated with CT, CV, CVV/a, and CSV/a in moderate and late stages of DR. Choroidal parameters decreased in PRP-treated eyes except for an increase of CVI in the central area.
Choroid was thinning in treatment-naïve DR eyes. Specifically, choroid decreased in the early stage and further increased with DR progression; increased expression of VEGF may be a key factor in choroidal thickening. PRP treatment could contribute to the redistribution of choroidal blood flow and improve the perfusion of the macula.
通过超广角扫频源光学相干断层扫描血管造影(UWF-SS-OCTA)的容积测量,研究糖尿病视网膜病变(DR)不同阶段脉络膜的变化,并确定全视网膜光凝(PRP)对脉络膜的影响。
这项观察性研究纳入了56名健康对照者、192名未经治疗的DR患者以及42名接受PRP治疗的DR患者,所有患者均接受了UWF-SS-OCTA测量。未经治疗的DR患者根据DR的不同严重程度进一步分组。根据中央和周边区域对这些组的脉络膜参数进行分析和比较。采用Spearman分析确定无灌注区(NPA)与脉络膜参数之间的关联。
与健康对照者相比,未经治疗的DR患者全范围的脉络膜厚度(CT)和容积(CV),包括血管和基质容积(CVV/a和CSV/a)均降低,而脉络膜血管指数(CVI)仅在周边区域降低(P = 0.04)。具体而言,无DR(NDR)和轻度非增殖性DR患者的脉络膜变薄,随后在DR的中度和晚期呈增加趋势。在DR的中度和晚期,NPA与CT、CV、CVV/a和CSV/a呈正相关。PRP治疗的眼中脉络膜参数降低,但中央区域的CVI增加除外。
未经治疗的DR眼中脉络膜变薄。具体而言,脉络膜在早期减少,并随着DR进展进一步增加;血管内皮生长因子(VEGF)表达增加可能是脉络膜增厚的关键因素。PRP治疗有助于脉络膜血流重新分布,并改善黄斑灌注。